An overview of chagasic cardiomyopathy: Pathogenic importance of oxidative stress

Anais da Academia Brasileira de Ciencias

Volumn 77, Issue 4, 2005, Pages 695-715

  Zacks, Michele A ^a   Wen, Jian Jun ^a   Vyatkina, Galina ^a   Bhatia, Vandanajay ^a   Garg, Nisha ^b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Chagasic cardiomyopathy; Inflammation; Mitochondria; Oxidant antioxidant status; Oxidative damage; Reactive oxygen species

Indexed keywords

EID: 31044453296     PISSN: 00013765     EISSN: 00013765     Source Type: Journal    
DOI: 10.1590/S0001-37652005000400009     Document Type: Article

References (151)

1. ALARCON-CORREDOR OM, CARRASCO-GUERRA H, RAMIREZ DE ERNANDEZ M AND LEON W. 2002. Serum enzyme pattern and local enzyme gradients in chronic chagasic patients. Acta Cient Venez 53: 210-217.
2. ALIBERTI JC, CARDOSO MA, MARTINS GA, GAZZINELLI RT, VIEIRA LQ AND SILVA JS. 1996. Interleukin-12 mediates resistance to Trypanosoma cruzi in mice and is produced by murine macrophages in response to live trypomastigotes. Infect Immun 64: 1961-1967.
3. ALIBERTI JC, SOUTO JT, MARINO AP, LANNES VIEIRA J, TEIXEIRA MM, FARBER J, GAZZINELLI RT AND SILVA JS. 2001. Modulation of chemokine production and inflammatory responses in interferon-gamma- and tumor necrosis factor-R1-deficient mice during Trypanosoma cruzi infection. Am J Pathol 158: 1433-1440.
4. ANDRADE SG, RASSI A, MAGALHAES JB, FERRIOLLI FILHO F AND LUQUETTI AO. 1992. Specific chemotherapy of Chagas disease: a comparison between the response in patients and experimental animals inoculated with the same strains. Trans R Soc Trop Med Hyg 86: 624-626.
5. ANDREW PJ AND MAYER B. 1999. Enzymatic function of nitric oxide synthases. Cardiovasc Res 43: 521-531.
6. BABIOR BM. 1999. NADPH oxidase: an update. Blood 93: 1464-1476.
7. BACHMAIER K, NEU N, PUMMERER C, DUNCAN GS, MAK TW, MATSUYAMA T AND PENNINGER JM. 1997. iNOS expression and nitrotyrosine formation in the myocardium in response to inflammation is controlled by the Interferon regulatory transcription factor 1. Circulation 96: 585-591.
8. BAHIA-OLIVEIRA LM ET AL. 1998. IFN-gamma in human Chagas' disease: protection or pathology? Braz J Med Biol Res 31: 127-131.
9. BEARD CB, PYE G, STEURER FJ, RODRIGUEZ R, CAMPMAN R, PETERSON AT, RAMSEY J, WIRTZ RA AND ROBINSON LE. 2003. Chagas disease in a domestic transmission cycle, southern Texas, USA. Emerg Infect Dis 9: 103-105.
10. BENIT P ET AL. 2001. Large-scale deletion and point mutations of the nuclear NDUFV1 and NDUFS1 genes in mitochondrial complex I deficiency. Am J Hum Genet 68: 1344-1352.
11. BERRY CE AND HARE JM. 2004. Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J Physiol 555: 589-606.
12. BRADLEY KK, BERGMAN DK, WOODS JP, CRUTCHER JM AND KIRCHHOFF LV. 2000. Prevalence of American trypanosomiasis (Chagas disease) among dogs in Oklahoma. J Am Vet Med Assoc 217: 1853-1857.
13. BRENER Z AND GAZZINELLI RT. 1997. Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease. Int Arch Allergy Immunol 114: 103-110.
14. BURLEIGH BA AND ANDREWS NW. 1995. The mechanisms of Trypanosoma cruzi invasion of mammalian cells. Annu Rev Microbiol 49: 175-200.
15. BUTTERFIELD DA ET AL. 1998. Structural and functional changes in proteins induced by free radical-mediated oxidative stress and protective action of the antioxidants N - tert - butyl - alpha - phenylnitrone and vitamin E. Ann N Y Acad Sci 854: 448-462.
16. CANDEIAS LP, PATEL KB, STRATFORD MR AND WARDMAN P. 1993. Free hydroxyl radicals are formed on reaction between the neutrophil-derived species superoxide anion and hypochlorous acid. FEBS Lett 333: 151-153.
17. CARDOSO SM, PEREIRA C AND OLIVEIRA R. 1999. Mitochondrial function is differentially affected upon oxidative stress. Free Radic Biol Med 26: 3-13.
18. CARRASCO GUERRA HA, PALACIOS-PRU E, DAGERT DE SCORZA C, MOLINA C, INGLESSIS G AND MENDOZA RV. 1987. Clinical, histochemical, and ultrastructural correlation in septal endomyocardial biopsies from chronic chagasic patients: detection of earlymyocardialdamage. Am Heart J 113: 716-724.
19. CARRASCO HA, ALARCON M, OLMOS L, BURGUERA J, BURGUERA M, DIPAOLO A AND CARRASCO HR. 1997. Biochemical characterization of myocardial damage in chronic Chagas' disease. Clin Cardiol 20: 865-869.
20. CARROLL J, FEARNLEY IM, SHANNON RJ, HIRST J AND WALKER JE. 2003. Analysis of the subunit composition of complex I from bovine heart mitochondria. Mol Cell Proteomics 2: 117-126.
21. CHANDRA M ET AL. 2002. Significance of inducible nitric oxide synthase in acute myocarditis caused by Trypanosoma cruzi (Tulahuen strain). Int J Parasitol 32: 897-905.
22. CHEN Q, VAZQUEZ EJ, MOGHADDAS S, HOPPEL CL AND LESNEFSKY EJ. 2003. Production of reactive oxygen species by mitochondria: Central role of complex III. J Biol Chem 278: 36027-36031.
23. CHEVION M, BERENSHTEIN E AND STADTMAN ER. 2000. Human studies related to protein oxidation: protein carbonyl content as a marker of damage. Free Radic Res 33 (Suppl.): S99-108.
24. COON MJ, DING XX, PERNECKY SJ AND VAZ AD. 1992. Cytochrome P450: progress and predictions. Faseb J 6: 669-673.
25. CORREA-OLIVEIRA R ET AL. 1999. The role of the immune response on the development of severe clinical forms of human Chagas disease. Mem Inst Oswaldo Cruz 94 (Suppl.1): 253-255.
26. CROSS AR, YARCHOVER JL AND CURNUTTE JT. 1994. The superoxide-generating system of human neutrophils possesses a novel diaphorase activity. Evidence for distinct regulation of electron flow within NADPH oxidase by p67-phox and p47-phox. J Biol Chem 269: 21448-21454.
27. DALLE-DONNE I, GIUSTARINI D, COLOMBO R, ROSSI R AND MILZANI A. 2003. Protein carbonylation in human diseases. Trends Mol Med 9: 169-176.
28. D'ALMEIDA P, KEITEL E, BITTAR A, GOLDANI J, SANTOS A, NEUMANN J AND GARCIA V. 1996. Long-term evaluation of kidney donors. Transplant Proc 28: 93-94.
29. DE SOUZA AP, MELO DE OLIVEIRA G, NEVE J, VAN-DERPAS J, PIRMEZ C, DE CASTRO SL, ARAUJO-JORGE TC AND RIVERA MT. 2002. Trypanosoma cruzi: host selenium deficiency leads to higher mortality but similar parasitemia in mice. Exp Parasitol 101: 193-199.
30. DE SOUZA AP, DE OLIVEIRA GM, VANDERPAS J, DE CASTRO SL, RIVERA MT AND ARAUJO-JORGE TC. 2003. Selenium supplementation at low doses contributes to the decrease in heart damage in experimental Trypanosoma cruzi infection. Parasitol Res 91: 51-54.
31. DODD RY AND LEIBY DA. 2004. Emerging infectious threats to the blood supply. Annu Rev Med 55: 191-207.
32. DROGE W. 2002. Free radicals in the physiological control of cell function. Physiol Rev 82: 47-95.
33. EISERICH JP ET AL. 2002. Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science 296: 2391-2394.
34. ELIZARI MV. 2002. Arrhythmias associated with Chagas' heart disease. Card Electrophysiol Rev 6: 115-119.
35. ESTERBAUER H. 1982. Aldehydic producs of lipid peoxidation. In: Free radicals, lipid peroxidation and cancer. McBrien DCH and Slater TF (Eds), Academic Press, London, p. 101-128.
36. EVANS MD AND COOKE MS. 2004. Factors contributing to the outcome of oxidative damage to nucleic acids. Bioessays 26: 533-542.
37. FINKEL T. 2003. Oxidant signals and oxidative stress. Curr Opin Cell Biol 15: 247-254.
38. FLOYD RA, WEST M AND HENSLEY K. 2001. Oxidative biochemical markers; clues to understanding aging in long-lived species. Exp Gerontol 36: 619-640.
39. FRIDOVICH I. 1974. Superoxide dismutases. Adv Enzymol Relat Areas Mol Biol 41: 35-97.
40. GARG N AND TARLETON RL. 2002. Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection. Infect Immun 70: 5547-5555.
41. GARG N, NUNES MP AND TARLETON RL. 1997. Delivery by Trypanosoma cruzi of proteins into the MHC class I antigen processing and presentation pathway. J Immunol 158: 3293-3302.
42. GARG N, POPOV VL AND PAPACONSTANTINOU J. 2003. Profiling gene transcription reveals a deficiency of mitochondrial oxidative phosphorylation in Trypanosoma cruzi'-infected murine hearts: implications in chagasic myocarditis development. Biochim Biophys Acta 1638: 106-120.
43. GARG N, BHATIA V, GERSTNER A, DEFORD J AND PAPACONSTANTINOU J. 2004. Gene expression analysis in mitochondria from chagasic mice: Alterations in specific metabolic pathways. Biochemical J 381: 743-752.
44. GAZZINELLI RT, OSWALD IP, HIENY S, JAMES SL AND SHER A. 1992. The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhabitable by interleukin-10 and transforming growth factor-beta. Eur J Immunol 22: 2501-2506.
45. GOLDSTEIN S, MEYERSTEIN D AND CZAPSKI G. 1993. The Fenton reagents. Free Radic Biol Med 15: 435-445.
46. GOMEZ RM, SOLANA ME AND LEVANDER OA. 2002. Host selenium deficiency increases the severity of chronic inflammatory myopathy in Trypanosoma cruzi-inoculated mice. J Parasitol 88: 541-547.
47. GUZMAN B. 2001. Epidemiology of Chagas disease in Mexico: an update. Trends Parasitol 17: 372-376.
48. HALLIWELL B. 1991. Reactive oxygen species in living systems: source, biochemistry, and role in human disease. Am J Med 91: 14S-22S.
49. HAN D, WILLIAMS E AND CADENAS E. 2001. Mitochondrial respiratory chain-dependent generation of superoxide anion and its release into the intermembrane space. Biochem J 353: 411-416.
50. HAN D, CANALI R, RETTORI D AND KAPLOWITZ N. 2003. Effect of glutathione depletion on sites and topology of Superoxide and hydrogen peroxide production in mitochondria. Mol Pharmacol 64: 1136-1144.
51. HAUPTMANN N, GRIMSBY J, SHIH JC AND CADENAS E. 1996. The metabolism of tyramine by monoamine oxidase A/B causes oxidative damage to mitochondrial DNA. Arch Biochem Biophys 335: 295-304.
52. HENSLEY K, ROBINSON KA, GABBITA SP, SALSMAN S AND FLOYD RA. 2000. Reactive oxygen species, cell signaling, and cell injury. Free Radic Biol Med 28: 1456-1462.
53. HERWALDT BL, GRIJALVA MJ, NEWSOME AL, MCGHEE CR, POWELL MR, NEMEC DG, STEURER FJ AND EBERHARD ML. 2000. Use of polymerase chain reaction to diagnose the fifth reported US case of autochthonous transmission of Trypanosoma cruzi, in Tennessee, 1998. J Infect Dis 181: 395-399.
54. HIGUCHI MD. 1995. Endomyocardial biopsy in Chagas' heart disease: pathogenetic contributions. São Paulo Med J 113: 821-825.
55. HIGUCHI MD, RIES MM, AIELLO VD, BENVENUTI LA, GUTIERREZ PS, BELLOTTI G AND PILEGGI F. 1997. Association of an increase in CD8+ T cells with the presence of Trypanosoma cruzi antigens in chronic, human, chagasic myocarditis. Am J Trop Med Hyg 56: 485-489.
56. HIGUCHI M DE L, BENVENUTI LA, MARTINS REIS M AND METZGER M. 2003. Pathophysiology of the heart in Chagas' disease: current status and new developments. Cardiovasc Res 60: 96-107.
57. Ho YS, MAGNENAT JL, BRONSON RT, CAO J, GARGANO M, SUGAWARA M AND FUNK CD. 1997. Mice deficient in cellular glutathione peroxidase develop normally and show no increased sensitivity to hyperoxia. J Biol Chem 272: 16644-16651.
58. HUANG H, CALDERON TM, BERMAN JW, BRAUNSTEIN VL, WEISS LM, WITTNER M AND TANOWITZ HB. 1999. Infection of endothelial cells with Trypanosoma cruzi activates NF-kappaB and induces vascular adhesion molecule expression. Infect Immun 67: 5434-5440.
59. IDE T, TSUTSUI H, KINUGAWA S, UTSUMI H, KANG D, HATTORI N, UCHIDA K, ARIMURA K, EGASHIRA K AND TAKESHITA A. 1999. Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium. Circ Res 85: 357-363.
60. IDE T, TSUTSUI H, HAYASHIDANI S, KANG D, SUEMATSU N, NAKAMURA K, UTSUMI H, HAMASAKI N AND TAKESHITA A. 2001. Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction. Circ Res 88: 529-535.
61. IWATA S, LEE JW, OKADA K, LEE JK, IWATA M, RASMUSSEN B, LINK TA, RAMASWAMY S AND JAP BK. 1998. Complete structure of the 11-subunit bovine mitochondrial cytochrome bcl complex. Science 281: 64-71.
62. JARDIM E AND TAKAYANAGUI OM. 1994. Chagasic meningoencephalitis with detection of Trypanosoma cruzi in the cerebrospinal fluid of an immunodepressed patient. J Trop Med Hyg 97: 367-370.
63. JONES EM, COLLEY DG, TOSTES S, LOPES ER, VNENCAK-JONES CL AND MCCURLEY TL. 1992. A Trypanosoma cruzi DNA sequence amplified from inflammatory lesions in human chagasic cardiomyopathy. Trans Assoc Am Physicians 105: 182-189.
64. JONES EM, COLLEY DG, TOSTES S, LOPES ER, VNENCAK-JONES CL AND MCCURLEY TL. 1993. Amplification of a Trypanosoma cruzi DNA sequence from inflammatory lesions in human chagasic cardiomyopathy. Am J Trop Med Hyg 48: 348-357.
65. KANNO T, FUJITA H, MURANAKA S, YANO H, UTSUMI T, YOSHIOKA T, INOUE M AND UTSUMI K. 2002. Mitochondrial swelling and cytochrome c release: sensitivity to cyclosporin A and calcium. Physiol Chem Phys Med NMR 34: 91-102.
66. KATSANOS KH, PAPPAS CJ, PATSOURAS D, MICHALIS LK, KITSIOS G, ELISAF M AND TSIANOS EV. 2002. Alarming atrioventricular block and mitral valve prolapse in the Kearns-Sayre syndrome. Int J Cardiol 83: 179-181.
67. KIRKINEZOS IG AND MORAES CT. 2001. Reactive oxygen species and mitochondrial diseases. Semin Cell Dev Biol 12: 449-457.
68. KOBERLE F. 1968. Chagas' disease and Chagas' syndromes: the pathology of American trypanosomiasis. Adv Parasitol 6: 63-116.
69. KORGE P, HONDA HM AND WEISS JN. 2001. Regulation of the mitochondrial permeability transition by matrix Ca(2+) and voltage during anoxia/ reoxygenation. Am J Physiol Cell Physiol 280: C517-526.
70. KURIHARA H, YOSHIZUMI M, SUGIYAMA T, TAKAKU F, YANAGISAWA M, MASAKI T, HAMAOKI M, KATO H AND YAZAKI Y. 1989. Transforming growth factor-beta stimulates the expression of endothelin mRNA by vascular endothelial cells. Biochem Biophys Res Commun 159: 1435-1440.
71. LEIBY DA ET AL. 2000. Evidence of Trypanosoma cruzi infection (Chagas' disease) among patients undergoing cardiac surgery. Circulation 102: 2978-2982.
72. LEON JS, GODSEL LM, WANG K AND ENGMAN DM. 2001. Cardiac myosin autoimmunity in acute Chagas' heart disease. Infect Immun 69: 5643-5649.
73. LESNEFSKY EJ, GUDZ TI, MIGITA CT, IKEDA-SAITO M, HASSAN MO, TURKALY PJ AND HOPPEL CL. 2001. Ischemic jury to mitochondrial electron transport in the aging heart: damage to the iron-sulfur protein subunit of electron transport complex III. Arch Biochem Biophys 385: 117-128.
74. LI Y ET AL. 1995. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet 11: 376-381.
75. LIANG Q AND MOLKENTIN JD. 2002. Divergent signaling pathways converge on GATA4 to regulate cardiac hypertrophic gene expression. J Mol Cell Cardiol 34: 611-616.
76. LOEFFEN J, ELPELEG O, SMEITINK J, SMEETS R, STOCKLER-ISIROGLU S, MANDEL H, SENGERS R, TRIJBELS F AND VAN DEN HEUVEL L. 2001. Mutations in the complex INDUFS2 gene of patients with cardiomyopathy and encephalomyopathy. Ann Neurol 49: 195-201.
77. LOSCHEN G, FLOHE L AND CHANCE B. 1971. Respiratory chain linked H(2)O(2) production in pigeon heart mitochondria. FEBS Lett 18: 261-264.
78. MARIN-NETO JA. 1998. Cardiac dysautonomia and pathogenesis of Chagas' heart disease. Int J Cardiol 66: 129-131.
79. MARNETT LJ. 2000. Oxyradicals and DNA damage. Carcinogenesis 21: 361-370.
80. MARTINDALE JL AND HOLBROOK NJ. 2002. Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol 192: 1-15.
81. MARTINS G A, CARDOSO MA, ALIBERTI JC AND SILVA JS. 1998. Nitric oxide-induced apoptotic cell death in the acute phase of Trypanosoma cruzi infection in mice. Immunol Lett 63: 113-120.
82. MCINTYRE M, BOHR DF AND DOMINICZAK AF. 1999. Endothelial function in hypertension: the role of superoxide anion. Hypertension 34: 539-545.
83. MEDRANO CJ AND Fox DA. 1994. Substrate-dependent effects of calcium on rat retinal mitochondrial respiration: physiological and toxicological studies. Toxicol Appl Pharmacol 125: 309-321.
84. MEURS KM, ANTHONY MA, SLATER M AND MILLER MW. 1998. Chronic Trypanosoma cruzi infection in dogs: 11 cases (1987-1996). J Am Vet Med Assoc 213: 497-500.
85. MILES M.2003. Americantrypanosomiasis (Chagas disease). In: Manson's tropical disease, 2nd Ed. (Cook G and Zumla A Eds), Elsevier Science, London, p. 1325-1337.
86. MINOPRIO P, EISEN H, JOSKOWICZ M, PEREIRA P AND COUTINHO A. 1987. Suppression of poly-clonal antibody production in Trypanosoma cruziinfected mice by treatment with anti-L3T4 antibodies. J Immunol 139: 545-550.
87. MIYAUCHI T AND MASAKI T. 1999. Pathophysiology of endothelin in the cardiovascular system. Annu Rev Physiol 61: 391-415.
88. MONTEIRO FA, ESCALANTE AA AND BEARD CB. 2001. Molecular tools and triatomine systematics: a public health perspective. Trends Parasitol 17: 344-347.
89. MORTARA RA ET AL. 1999. Imaging Trypanosoma cruzi within tissues from chagasic patients using confocal microscopy with monoclonal antibodies. Parasitol Res 85: 800-808.
90. MOTT KE AND HAGSTROM JW. 1965. The Pathologic Lesions of the Cardiac Autonomic Nervous System inChronic Chagas' Myocarditis. Circulation 31: 273286.
91. MOTT KE, MUNIZ TM, LEHMAN JR JS, HOFF R, MORROW JR RH, DE OLIVEIRA TS, SHERLOCK I AND DRAPER CC. 1978. House construction, triatomine distribution, and household distribution of seroreactivity to Trypanosoma cruzi in a rural community in northeast Brazil. Am J Trop Med Hyg 27: 1116-1122.
92. MUKHERJEE S ET AL. 2003. Microarray analysis of changes in gene expression in a murine model of chronic chagasic cardiomyopathy. Parasitol Res 91: 187-196.
93. MURRAY J, TAYLOR SW, ZHANG B, GHOSH SS AND CAPALDI RA. 2003. Oxidative damage to mitochondrial complex I due to peroxynitrite: identification of reactive tyrosines by mass spectrometry. J Biol Chem 278: 37223-37230.
94. NOGUEIRA N AND COHN ZA. 1978. Trypanosoma cruzi: in vitro induction of macrophage microbicidal activity. J Exp Med 148: 288-300.
95. NORDBERG J AND ARNER ES. 2001. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic Biol Med 31: 1287-1312.
96. OCHS DE, HNILICA VS, MOSER DR, SMITH JH AND KIRCHHOFF LV. 1996. Postmortem diagnosis of autochthonous acute chagasic myocarditis by polymerase chain reaction amplification of a species-specific DNA sequence of Trypanosoma cruzi. Am J Trop Med Hyg 54: 526-529.
97. OLIVEIRA JS. 1985. A natural human model of intrinsic heart nervous system denervation: Chagas' cardiopathy. Am Heart J 110: 1092-1098.
98. PALACIOS-PRU E, CARRASCO H, SCORZA C AND ESPINOZA R. 1989. Ultrastructural characteristics of different stages of human chagasic myocarditis. Am J Trop Med Hyg 41:29-40.
99. PALMEIRA CM, SERRANO J, KUEHL DW AND WALLACE KB. 1997. Preferential oxidation of cardiac mitochondrial DNA following acute intoxication with doxorubicin. Biochim Biophys Acta 1321: 101-106.
100. PAPA S, SARDANELLI AM, SCACCO S, PETRUZZELLA V, TECHNIKOVA-DOBROVA Z, VERGARI R AND SIGNORILE A. 2002. The NADH: ubiquinone oxidoreductase (complex I) of the mammalian respi ratory chain and the cAMP cascade. J Bioenerg Biomembr 34: 1-10.
101. PARADA H, CARRASCO HA, ANEZ N, FUENMAYOR C AND INGLESSIS I. 1997. Cardiac involvement is a constant finding in acute Chagas' disease: a clinical, parasitological and histopathological study. Int J Cardiol 60: 49-54.
102. PEREZ-FUENTES R ET AL. 2003. Severity of chronic Chagas disease is associated with cytokine/antioxidant imbalance in chronically infected individuals. Int J Parasitol 33: 293-299.
103. PETKOVA SB, ASHTON A, BOUZAHZAH B, HUANG H, PESTELL RG AND TANOWITZ HB. 2000a. Cell cycle molecules and diseases of the cardiovascular system. Front Biosci 5: D452-60.
104. PETKOVA SB ET AL. 2000b. Myocardial expression of endothelin-1 in murine Trypanosoma cruzi infection. Cardiovasc Pathol 9: 257-265.
105. PETKOVA SB ET AL. 2001. The role of endothelin in the pathogenesis of Chagas' disease. Int J Parasitol 31: 499-511.
106. PIPER HM, NOLL T AND SIEGMUND B. 1994. Mitochondrial function in the oxygen depleted and reoxygenated myocardial cell. Cardiovasc Res 28: 1-15.
107. PONTES-DE-CARVALHO L, SANTANA CC, SOARES MB, OLIVEIRA GG, CUNHA-NETO E AND RIBEIRO-DOS-SANTOS R. 2002. Experimental chronic Chagas' disease myocarditis is an autoimmune disease preventable by induction of immunological tolerance to myocardial antigens. J Autoimmun 18: 131-138.
108. RASSI JR A, RASSI A AND LITTLE WC. 2000. Chagas' heart disease. Clin Cardiol 23: 883-889.
109. REIS MM, HIGUCHI MDL, BENVENUTI LA, AIELLO VD, GUTIERREZ PS, BELLOTTI G AND PILEGGI F. 1997. An in situ quantitative immunohistochemical study of cytokines and IL-2R+ in chronic human chagasic myocarditis: correlation with the presence of myocardial Trypanosoma cruzi antigens. Clin Immunol Immunopathol 83: 165-172.
110. RIVERA MT ET AL. 2002. Progressive Chagas' cardiomyopathy is associated with low selenium levels. Am J Trop Med Hyg 66: 706-712.
111. ROCHA A ET AL. 1994. Pathology of patients with Chagas' disease and acquired immunodeficiency syndrome. Am J Trop Med Hyg 50: 261-268.
112. ROCHA MO, RIBEIRO AL AND TEIXEIRA MM. 2003. Clinical management of chronic Chagas cardiomyopathy. Front Biosci 8: e44-54.
113. ROSSI MA AND RAMOS SG. 1996. Coronary microvascular abnormalities in Chagas' disease. Am Heart J 132: 207-210.
114. ROSSI MA, RAMOS SG AND BESTETTI RB. 2003. Chagas' heart disease: clinical-pathological correlation. Front Biosci 8: e94-109.
115. SALOMONE OA, JURI D, OMELIANIUK MO, SEMBAJ A, AGUERRI AM, CARRIAZO C, BARRAL JM AND MADOERY R. 2000. Prevalence of circulating Trypanosoma cruzi detected by polymerase chain reaction in patients with Chagas' cardiomyopathy. Am J Cardiol 85: 1274-1276.
116. SARTORI AM, LOPES MH, CARAMELLI B, DUARTE MI, PINTO PL, NETO V AND AMATO SHIKANAI-YASUDA M. 1995. Simultaneous occurrence of acute myocarditis and reactivated Chagas' disease in a patient with AIDS. Clin Infect Dis 21: 1297-1299.
117. SATO W ET AL. 1993. Deletion of mitochondrial DNA in a patient with conduction block. Am Heart J 125: 550-552.
118. SAWYER DB, SIWIK DA, XIAO L, PIMENTEL DR, SINGH K AND COLUCCI WS. 2002. Role of oxidative stress in myocardial hypertrophy and failure. J Mol Cell Cardiol 34: 379-388.
119. SCHOFIELD CJ AND DIAS JC. 1999. The Southern Cone Initiative against Chagas disease. Adv Parasitol 42: 1-27.
120. SCHUELKE M, SMEITINK J, MARIMAN E, LOEFFEN J, PLECKO B, TRIJBELS F, STOCKLER-IPSIROGLU S AND VAN DEN HEUVEL L. 1999. Mutant NDUFV1 subunit of mitochondrial complex I causes leukodystrophy and myoclonic epilepsy. Nat Genet 21: 260-261.
121. SERRANO J, PALMEIRA CM, KUEHL DW AND WALLACE KB. 1999. Cardioselective and cumulative oxidation of mitochondrial DNA following subchronic doxorubicin administration. Biochim Biophys Acta 1411: 201-205.
122. SOARES MB AND SANTOS RR. 1999. Immunopathology of cardiomyopathy in the experimental Chagas disease. Mem Inst Oswaldo Cruz 94: 257-262.
123. SOARES MB, PONTES-DE-CARVALHO L AND RIBEIRO-DOS-SANTOS R. 2001. The pathogenesisof Chagas' disease: when autoimmune and parasite-specific immune responses meet. An Acad Bras Cienc 73: 547-559.
124. TANOWITZ HB ET AL. 1992. Cytokine gene expression of endothelial cells infected with Trypanosoma cruzi. J Infect Dis 166: 598-603.
125. TARLETON RL. 1990. Depletion of CD8+ T cells increases susceptibility and reverses vaccine-induced immunity in mice infected with Trypanosoma cruzi. J Immunol 144: 717-724.
126. TARLETON RL, KOLLER BH, LATOUR A AND POSTAN M. 1992. Susceptibility of beta 2-microglobulin-deficient mice to Trypanosoma cruzi infection. Nature 356: 338-340.
127. THOMSON SA, SHERRITT MA, MEDVECZKY J, ELLIOTT SL, MOSS DJ, FERNANDO GJ, BROWN LE AND SUHRBIER A. 1998. Delivery of multiple CDS cytotoxic T cell epitopes by DNA vaccination. J Immunol 160: 1717-1723.
128. TOKORO T, ITO H AND SUZUKI T. 1996. Alterations in mitochondrial DNA and enzyme activities in hypertrophied myocardium of stroke-prone SHRS. Clin Exp Hypertens 18: 595-606.
129. TORRICO F, HEREMANS H, RIVERA MT, VAN MARCK E, BILLIAU A AND CARLIER Y. 1991. Endogenous IFN-gamma is required for resistance to acute Trypanosoma cruzi infection in mice. J Immunol 146: 3626-3632.
130. TURRENS JF. 2003. Mitochondrial formation of reactive oxygen species. J Physiol 552: 335-344.
131. TURRENS JF. 2004. Oxidative stress and antioxidant defenses: a target for the treatment of diseases caused by parasitic protozoa. Mol Aspects Med 25: 211-220.
132. UCHIDA K AND STADTMAN ER. 1992. Modification of histidine residues in proteins by reaction with 4hydroxynonenal. Proc Natl Acad Sci USA 89: 4544-4548.
133. UEDA S, MASUTANI H, NAKAMURA H, TANAKA T, UENO M AND YODOI J. 2002. Redox control of cell death. Antioxid Redox Signal 4: 405-414.
134. UYEMURA SA, ALBUQUERQUE S AND CURTI C. 1995. Energetics of heart mitochondria during acute phase of Trypanosoma cruzi infection in rats. Int J Biochem Cell Biol 27: 1183-1189.
135. VAN REMMEN H, WILLIAMS MD, Quo Z, ESTLACK L, YANG H, CARLSON EJ, EPSTEIN CJ, HUANG TT AND RICHARDSON A. 2001. Knockout mice heterozygous for Sod2 show alterations in cardiac mitochondrial function and apoptosis. Am J Physiol Heart Circ Physiol 281: H1422-1432.
136. VERCESI AE, KOWALTOWSKI AJ, GRIJALBA MT, MEINICKE AR AND CASTILHO RF. 1997. The role of reactive oxygen species in mitochondrial permeability transition. Biosci Rep 17: 43-52.
137. VESPA GN, CUNHA FQ AND SILVA JS. 1994. Nitric oxide is involved in control of Trypanosoma cruziinduced parasitemia and directly kills the parasite in vitro. Infect Immun 62: 5177-5182.
138. VIOTTI R, VIGLIANO C, ARMENTI H AND SEGURA E. 1994. Treatment of chronic Chagas' disease with benznidazole: clinical and serologic evolution of patients with long-term follow-up. Am Heart J 127: 151-162.
139. VYATKINA G, BHATIA V, GERSTNER A, PAPACON-STANTINOU J AND GARG N. 2004. Impaired mitochondrial respiratory chain and bioenergetics during chagasic cardiomyopathy development. Biochim Biophys Acta 1689: 162-173.
140. WALLACE DC. 2000. Mitochondrial defects in cardiomyopathy and neuromuscular disease. Am Heart J 139: S70-85.
141. WEN J-J AND GARG N. 2004. Oxidative modifications of mitochondrial respiratory complexes in response to the stress of Trypanosoma cruzi infection. Free Radic Biol Med 37: 2072-2081.
142. WEN J-J, VYATKINA G AND GARG N. 2004. Oxidative damage during chagasic cardiomyopathy development: Role of mitochondrial oxidant release and inefficient antioxidant defense. Free Radic Biol Med 37: 1821-1833.
143. WILLIAMS MD, VAN REMMEN H, CONRAD CC, HUANG TT, EPSTEIN CJ AND RICHARDSON A. 1998. Increased oxidative damage is correlated to altered mitochondrial function in heterozygous manganese superoxide dismutase knockout mice. J Biol Chem 273: 28510-28515.
144. WINTERBOURN CC, VISSERS MC AND KETTLE AJ. 2000. Myeloperoxidase. Curr Opin Hematol 7: 53-58.
145. WITTNER M ET AL. 1995. Trypanosoma cruzi induces endothelin release from endothelial cells. J Infect Dis 171: 493-497.
146. WIZEL B, NUNES M AND TARLETON RL. 1997. Identification of Trypanosoma cruzi trans-sialidase family members as targets of protective CD8+ TC1 responses. J Immunol 159: 6120-6130.
147. WIZEL B, GARG N AND TARLETON RL. 1998. Vaccination with trypomastigote surface antigen 1-encoding plasmid DNA confers protection against lethal Trypanosoma cruzi infection. Infect Immun 66: 5073-5081.
148. WORLD HEALTH ORGANIZATION. 2002. Control of chagas disease: second report of the WHO expert committee Strategic Direction for Research. Geneva Switzerland, p 1-159.
149. YABSLEY MJ AND NOBLET GP. 2002. Seroprevalence of Trypanosoma cruzi in raccoons from South Carolina and Georgia. J Wildl Dis 38: 75-83.
150. YANAGISAWA M, KURIHARA H, KIMURA S, TOMOBE Y, KOBAYASHI M, MITSUI Y, YAZAKI Y, GOTO K AND MASAKI T. 1988. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415.
151. ZARKOVIC N. 2003. 4-Hydroxynonenal as a bioactive marker of pathophysiological processes. Mol Aspects Med 24: 281-291.